Acro Biomedical Co., Ltd. (ACBM) stock
ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.56MP/E –Yield –
Acro Biomedical gross margin
Gross margin is gross profit as a percentage of revenue.
Acro Biomedical's gross margin for the twelve months ending Sep 30, 2023 was 17.8%. For fiscal 2022 it was 21.3%, against 21.7% the year before. The highest annual figure on record is 21.7% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 21.3% | −0.3 |
| FY2021 | Dec 31, 2021 | 21.7% | +11.7 |
| FY2019 | Sep 30, 2019 | 10.0% | −0.4 |
| FY2018 | Sep 30, 2018 | 10.4% | +0.4 |
| FY2017 | Sep 30, 2017 | 10.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | 17.8% | −11.9 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | 25.6% | +15.6 |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | 25.1% | +14.6 |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | 16.0% | +5.1 |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | 29.6% | +19.6 |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | 10.0% | +0.0 |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | 10.5% | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | 10.9% | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | 10.0% | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | 10.0% | – |
See a number that looks wrong?